Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy
- PMID: 29761007
- PMCID: PMC5943772
- DOI: 10.1002/brb3.952
Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy
Abstract
Background: Major depressive disorders are characterized by their severity and long-lasting symptoms, which make such disorders highly disabling illnesses. Unfortunately, 50% of major depressive patients experience relapses, perhaps partly because drug research has been performed only in animal models that screen for antidepressant drugs that appear to only ameliorate acute depression symptoms. The bilateral olfactory bulbectomy (OBX) animal model presents the advantage of mimicking the symptoms of chronic depression by means of brain surgery. Adenosine purinergic receptors A2A (A2AR) have been the target of interest in the field of psychiatric diseases. This study aimed to show which A2A receptor ligands exert antidepressive-like effects in the OBX rat model.
Methods: Forty Sprague-Dawley male rats were divided into four groups: control, OBX + vehicle, OBX + ZM 241385, and OBX + adenosine groups. Pharmacological treatment was administered for 14 days, and the rats were examined via the forced swim test (FST), open field test (OFT), and sucrose preference test (SPT).
Results: The OBX + ZM 241385 group exhibited decreased immobility time in the FST, decreased isolation time in the OFT, and reversed anhedonia behavior in the SPT compared to the vehicle group. However, no significant differences for adenosine treatment were found.
Conclusions: ZM 241385 administration (2 mg/kg i.p.) restored behavioral changes associated with OBX-induced depression.
Keywords: A2A receptors; ZM 241385; adenosine; behavioral tests; major depressive disorder.
Figures





Similar articles
-
SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):101-6. doi: 10.1007/s00210-008-0336-1. Epub 2008 Jul 31. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18668225
-
Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats.Pharmacogn Mag. 2015 Oct;11(Suppl 3):S388-96. doi: 10.4103/0973-1296.168980. Pharmacogn Mag. 2015. PMID: 26929572 Free PMC article.
-
Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.Biol Psychiatry. 2007 Apr 15;61(8):990-5. doi: 10.1016/j.biopsych.2006.08.032. Epub 2006 Dec 4. Biol Psychiatry. 2007. PMID: 17141743
-
The olfactory bulbectomy model in mice and rat: one story or two tails?Eur J Pharmacol. 2015 Apr 15;753:105-13. doi: 10.1016/j.ejphar.2014.10.033. Epub 2014 Nov 7. Eur J Pharmacol. 2015. PMID: 25446558 Review.
-
The olfactory bulbectomized rat as a model of depression: The hippocampal pathway.Behav Brain Res. 2017 Jan 15;317:562-575. doi: 10.1016/j.bbr.2016.09.029. Epub 2016 Sep 12. Behav Brain Res. 2017. PMID: 27633561 Review.
Cited by
-
From purines to purinergic signalling: molecular functions and human diseases.Signal Transduct Target Ther. 2021 Apr 28;6(1):162. doi: 10.1038/s41392-021-00553-z. Signal Transduct Target Ther. 2021. PMID: 33907179 Free PMC article. Review.
-
CD73-Mediated Formation of Extracellular Adenosine Is Responsible for Adenosine A2A Receptor-Mediated Control of Fear Memory and Amygdala Plasticity.Int J Mol Sci. 2022 Oct 24;23(21):12826. doi: 10.3390/ijms232112826. Int J Mol Sci. 2022. PMID: 36361618 Free PMC article.
-
Adenosine A2A Receptors as Biomarkers of Brain Diseases.Front Neurosci. 2021 Jul 16;15:702581. doi: 10.3389/fnins.2021.702581. eCollection 2021. Front Neurosci. 2021. PMID: 34335174 Free PMC article. Review.
-
Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula.Nat Commun. 2023 Apr 5;14(1):1880. doi: 10.1038/s41467-023-37601-x. Nat Commun. 2023. PMID: 37019936 Free PMC article.
-
Research progress on adenosine in central nervous system diseases.CNS Neurosci Ther. 2019 Sep;25(9):899-910. doi: 10.1111/cns.13190. Epub 2019 Jul 23. CNS Neurosci Ther. 2019. PMID: 31334608 Free PMC article. Review.
References
-
- Abelaira, H. M. , Reus, G. Z. , & Quevedo, J. (2013). Animal models as tools to study the pathophysiology of depression. Revista Brasileira de Psiquiatria, 35, S112–S120. https://doi.org/10.1590/1516-4446-2013-1098 - DOI - PubMed
-
- American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM‐5®), 5th ed. Arlington, VA: American Psychiatric Publishing.
-
- Babinska, Z. , & Ruda‐kucerova, J. (2017). Differential characteristics of ketamine self‐administration in the olfactory bulbectomy model of depression in male rats. Experimental and Clinical Psychopharmacology, 25(2), 84–93. https://doi.org/10.1037/pha0000106 - DOI - PubMed
-
- Castagné, V , Moser, P. , Roux, S. , & Porsolt, R. D. (2011). “Rodent models of depression: Forced swim and tail suspension behavioral despair tests in rats and mice”. Current Protocols in Neuroscience, 55(8.10), 11–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous